कृपया अन्य खोज का प्रयास करें
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Pierre Belichard | - | - | Co-Founder and Chairman of the Board |
Jonathan Peled | - | - | Member of Advisory Board |
Mohamad Mohty | - | - | Member of Advisory Board (Medical Hematology – Oncology Advisor) |
Franck Carbonnel | - | 2022 | Member of Scientific Advisory Board |
Eric G. Pamer | - | - | Member of Advisory Board |
Hassane Zarour | - | 2022 | Member of Scientific Advisory Board |
Muriel Prudent | 36 | - | Non-Executive Director |
Isabelle de Cremoux | 53 | 2014 | Non-Executive Director |
Claude Bertrand | 61 | 2020 | Independent Non-Executive Director |
Herve Affagard | 48 | 2014 | CEO, Co-Founder & Director |
Dorothee Burkel | 59 | 2021 | Independent Non Executive Director |
Joel Dore | - | - | Co-Founder & Member of Scientific Advisory Board |
Jean Volatier | 58 | 2021 | Independent Non Executive Director |
Robert Jenq | - | 2020 | Member of Scientific Advisory Board |
Jean-Marie Lefevre | 64 | 2016 | Non-Executive Chairman of the Board |
Florent Malard | - | 2020 | Member of Scientific Advisory Board |
Ernst Holler | - | 2020 | Chair of Scientific Advisory Board |
Karim Dabbagh | - | 2023 | Independent Chairman |
Nadia Kamal | - | 2023 | Independent Director |
Robert Zeiser | - | 2020 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है